Elutia/$ELUT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Elutia
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Ticker
$ELUT
Sector
Primary listing
Employees
26
Headquarters
Website
Elutia Metrics
BasicAdvanced
$48M
1.30
$0.87
0.69
-
Price and volume
Market cap
$48M
Beta
0.69
52-week high
$2.64
52-week low
$0.50
Average daily volume
140K
Financial strength
Current ratio
2.22
Quick ratio
1.515
Long term debt to equity
12.963
Total debt to equity
14.245
Profitability
EBITDA (TTM)
-17.196
Gross margin (TTM)
53.66%
Net profit margin (TTM)
434.23%
Operating margin (TTM)
-149.78%
Effective tax rate (TTM)
-0.08%
Revenue per employee (TTM)
$470,000
Management effectiveness
Return on assets (TTM)
-23.37%
Return on equity (TTM)
170.77%
Valuation
Price to earnings (TTM)
1.299
Price to revenue (TTM)
3.807
Price to book
1.75
Price to tangible book (TTM)
1.85
Price to free cash flow (TTM)
-1.002
Free cash flow yield (TTM)
-99.75%
Free cash flow per share (TTM)
-1.127
Growth
Revenue change (TTM)
-49.57%
Earnings per share change (TTM)
-146.88%
3-year revenue growth (CAGR)
-19.82%
3-year earnings per share growth (CAGR)
-28.48%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Elutia stock?
Elutia (ELUT) has a market cap of $48M as of April 12, 2026.
What is the P/E ratio for Elutia stock?
The price to earnings (P/E) ratio for Elutia (ELUT) stock is 1.3 as of April 12, 2026.
Does Elutia stock pay dividends?
No, Elutia (ELUT) stock does not pay dividends to its shareholders as of April 12, 2026.
When is the next Elutia dividend payment date?
Elutia (ELUT) stock does not pay dividends to its shareholders.
What is the beta indicator for Elutia?
Elutia (ELUT) has a beta rating of 0.69. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.